Paper Presentation Guidelines

General Submission Eligibility

• Registration for ISA MIDKON 2026: Mandatory for the presenting author.
• Membership: The presenting author is required to be a Life Member/Associate Life Member of the ISA.
• Originality: The work must be original research and should not have been previously published or accepted for publication/presentation elsewhere.
• Presenting Author: The first author is typically the presenting author.

The abstract (not to exceed 250 words) shall contain the following headings:

1. Title
2. Introduction
3. Methodology
4. Results: One most relevant table/ image/graph/illustration
5. Discussion
6. Conclusion
7. References (Two, most relevant)

• Last date for submission of abstracts is strictly 31st January 2026
• No further requests will be entertained

Presentation Format (Oral Paper)

The presentation is usually a Microsoft PowerPoint file, adhering to a strict time and slide limit.

Aspect	Guidelines
Total Time Allotted	6 minutes (4 minutes for presentation, 2 minutes for Q&A)
Format	Microsoft PowerPoint only (no videos or animations are typically allowed).
Slide Count	Minimum 5, Maximum 10 slides, excluding the title and reference slides.
Slide Ratio	16:9 (Widescreen) is the standard aspect ratio.
Content per Slide	Maximum of 10 lines of text per slide to ensure readability

Standard Content Structure

Your presentation slides should strictly follow a scientific structure to maximize clarity within the time limit.

Section	Recommended Slides & Content
1. Title Slide	(1 slide): Title, Presenting Author's Name, Co-Authors, Affiliation/Institution, ISA Logo, and Institutional Logo.
2. Introduction	(1 slide): Background, Need for the study, and Aims & Objectives (Clearly define your research question).
3. Methodology	(2-3 slides): Type and design of the study, Ethical clearance/Trial registration (if applicable), Study location and population, Inclusion/Exclusion criteria, Sample size estimation, Interventions/Parameters studied, and Statistical analysis details.
4. Results	(2-3 slides): Details of demographics, Presentation of Primary and Secondary outcome measures. Use suitable illustrations (tables, graphs, or flowcharts) to depict key findings. Do not repeat values already presented in tables/figures.
5. Discussion	(2 slides): Inferences drawn from your results, comparison with previous literature, discussion of confounding variables, and Limitations of the study.
6. Conclusion	(1 slide): Precise and focused conclusion that directly addresses the primary aim of the study. Do not include limitations or future scope here.
7. References	(1 slide): Only pertinent and relevant references (usually maximum of 5

Key Cautions

• Avoid Plagiarism: Submissions typically undergo a plagiarism check (often < 25% similarity index is allowed).
• Professionalism: Maintain a balanced view of therapeutic options; use generic names for drugs where possible.
• Proofread: Ensure all slides and the abstract are free of errors

Contact

For any queries, contact us:
Email: isamalanad2018@gmail.com
Mobile: +91 944 720 9010